ELIAS Animal Health Blog
Read the latest news and updates from ELIAS Animal Health
An Entrepreneur’s Journey: Can Cancer in Dogs Be Treated Without Chemotherapy?
Entrepreneurs look to solve problems. Needs spark ideas, ideas spark innovation, and innovation births new companies. We founded ELIAS Animal [...]
ELIAS Cancer Immunotherapy Gives Dogs with Osteosarcoma More Days at Home
Recent advancements in canine cancer treatment offer the potential for better outcomes, especially the advancements in immunotherapy treatments. A discussion [...]
Canine Cancer Continuum | Part 3: How Immunotherapy Works
In this final installment of the Canine Cancer Continuum, we talk about immunotherapy - what it is, how it works, [...]
Canine Cancer Continuum | Part 2: The Connection Between Canine and Human Cancer
We’re halfway through a series exploring canine cancer. Last week, we discussed the prevalence of dog cancer, and today we [...]
Canine Cancer Continuum | Part 1: The Prevalence of Dog Cancer
We’re embarking on a 3-part series that explores dog cancer, how our research and progress can be applied to humans, [...]
ELIAS Animal Health Expands Scientific Advisory Board
Nov. 23, 2021 — ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, [...]
ELIAS Animal Health In-Licenses Oncolytic Vaccinia Virus Treatment for Pet Animals from Genelux Corporation
Agreement grants ELIAS Animal Health the worldwide right to development and commercialization of V-VET1 for the diagnosis, prevention and treatment [...]